Dr Prem Mahendra is the leading private consultant haemato-oncologist in the West Midlands. For more than 25 years she has been providing an unparalleled, empathetic and efficient service for patients with blood cancer, and is passionate about delivering outstanding care. Private patients are seen either at the Priory Hospital, Edgbaston, Birmingham or at the HCA Harborne Hospital, Edgbaston, Birmingham.
She is an NHS consultant at the Queen Elizabeth Hospital, Birmingham.
Areas of expertise are care of patients with:
- Non-Hodgkin lymphoma
- Hodgkin lymphoma
- Myeloma
- Acute myeloid and lymphoblastic leukaemia
- Chronic lymphocytic and myeloid leukaemia
- Myelodysplasia
- Myeloproliferative disorder
- Waldenstroms macroglobulinaemia
And those undergoing:
- Autologous stem cell transplantation
- Allogeneic stem cell transplantation.
- CAR-T (chimeric antigen receptor-T-cell therapy)
![](https://premmahendra.co.uk/wp-content/uploads/2021/05/Blood_Cancer_UK.jpg)
![](https://premmahendra.co.uk/wp-content/uploads/2021/05/MyelomaUK.jpg)
![Lymphoma_Action](https://premmahendra.co.uk/wp-content/uploads/2021/05/Lymphoma_Action.jpg)
Latest News
Diffuse-large B-cell lymphoma – Ground breaking new treatment available for relapsed/refractory patients
For over 30-years autologous stem cell transplantation has been the standard of care for patients with relapsed diffuse-large B-cell lymphoma (DLBCL). The international Zuma-7 trial...
Hodgkin Lymphoma? A new standard of care for advanced stage patients
For decades the standard treatment for patients with advanced Hodgkin lymphoma has been combination chemotherapy with either ABVD or escalated BEACOPP. Approximately 5 years ago...
Myeloma Treatment – “remarkably effective” in the treatment of myeloma
Whilst access to CAR-T therapy is only available by entry into clinical trials in the UK currently, recent results of ciltacabtagene autoleucel (also known as...